Transfusion of older stored blood worsens outcomes in canines depending on the presence and severity of pneumonia

Transfusion

Volumn 54, Issue 7, 2014, Pages 1712-1724

  Wang, Dong ^a   Cortés Puch, Irene ^a   Sun, Junfeng ^a   Solomon, Steven B ^a   Kanias, Tamir ^a   Remy, Kenneth E ^a   Feng, Jing ^a   Alimchandani, Meghna ^b   Quezado, Martha ^b   Helms, Christine ^c   Perlegas, Andreas ^c   Gladwin, Mark T ^a,d   Kim Shapiro, Daniel B ^c   Klein, Harvey G ^e   Natanson, Charles ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d WAKE FOREST UNIVERSITY   (United States)

^e UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; HEMOLYSIN; IRON; TRANSFERRIN;

ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEAGLE; BLOOD DONOR; BLOOD STORAGE; BLOOD TRANSFUSION; COLONY FORMING UNIT; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; EXCHANGE BLOOD TRANSFUSION; HEMOGLOBIN BLOOD LEVEL; HEMOLYSIS; IRON BLOOD LEVEL; LUNG INJURY; MORTALITY; NONHUMAN; OUTCOME ASSESSMENT; PNEUMONIA; SEPTIC SHOCK; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

ACUTE LUNG INJURY; ANIMALS; BLOOD PRESERVATION; DISEASE MODELS, ANIMAL; DOGS; EXCHANGE TRANSFUSION, WHOLE BLOOD; IRON; PNEUMONIA, STAPHYLOCOCCAL; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STAPHYLOCOCCUS AUREUS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84904466361     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12607     Document Type: Article

References (52)

1. World Organization of Health. Global database on blood safety: report 2004-2005. Geneva, Switzerland: World Health Organization. 2008.
2. Whitaker BI, Schlumpf K, Schulman J, et al. The 2009 national blood collection and utilization survey report. Washington, DC: US Department of Health and Human Services. 2011.
3. Koch CG, Li L, Sessler DI, et al. Duration of red-cell storage and complications after cardiac surgery. N Engl J Med 2008; 358: 1229-1239.
4. Baek JH, D'Agnillo F, Vallelian F, et al. Hemoglobin-driven pathophysiology is an in vivo consequence of the red blood cell storage lesion that can be attenuated in guinea pigs by haptoglobin therapy. J Clin Invest 2012; 122: 1444-1458.
5. Hod EA, Spitalnik SL,. Stored red blood cell transfusions: iron, inflammation, immunity, and infection. Transfus Clin Biol 2012; 19 (3): 84-89.
6. Hess JR, Greenwalt TG,. Storage of red blood cells: new approaches. Transfus Med Rev 2002; 16: 283-295.
7. Solomon SB, Wang D, Sun J, et al. Mortality increases after massive exchange transfusion with older stored blood in canines with experimental pneumonia. Blood 2013; 121: 1663-1672.
8. Donadee C, Raat NJ, Kanias T, et al. Nitric oxide scavenging by red blood cell microparticles and cell-free hemoglobin as a mechanism for the red cell storage lesion. Circulation 2011; 124: 465-476.
9. Baron DM, Yu B, Lei C, et al. Pulmonary hypertension in lambs transfused with stored blood is prevented by breathing nitric oxide. Anesthesiology 2012; 116: 637-647.
10. Hod EA, Zhang N, Sokol SA, et al. Transfusion of red blood cells after prolonged storage produces harmful effects that are mediated by iron and inflammation. Blood 2010; 115: 4284-4292.
11. Hod EA, Brittenham GM, Billote GB, et al. Transfusion of human volunteers with older, stored red blood cells produces extravascular hemolysis and circulating non-transferrin-bound iron. Blood 2011; 118: 6675-6682.
12. Bullen JJ, Rogers HJ, Spalding PB, et al. Iron and infection: the heart of the matter. FEMS Immunol Med Microbiol 2005; 43: 325-330.
13. Bullen J, Griffiths E, Rogers H, et al. Sepsis: the critical role of iron. Microbes Infect 2000; 2: 409-415.
14. Wang D, Sun J, Solomon SB, et al. Transfusion of older stored blood and risk of death: a meta-analysis. Transfusion 2012; 52: 1184-1195.
15. Lacroix J, Hebert P, Fergusson D, et al. The Age of Blood Evaluation (ABLE) randomized controlled trial: study design. Transfus Med Rev 2011; 25: 197-205.
16. Heddle NM, Cook RJ, Arnold DM, et al. The effect of blood storage duration on in-hospital mortality: a randomized controlled pilot feasibility trial. Transfusion 2012; 52: 1203-1212.
17. Australian and New Zealand Intensive Care Research Center. Standard issue transfusion versus fresher red cell use in intensive care: a randomized controlled trial (TRANSFUSE). July 9, 2012. [cited 2014 Feb 13]. Available from: http://clinicaltrials.gov/ct2/show/NCT01638416
18. Steiner ME, Assmann SF, Levy JH, et al. Addressing the question of the effect of RBC storage on clinical outcomes: the Red Cell Storage Duration Study (RECESS) (Section 7). Transfus Apher Sci 2010; 43: 107-116.
19. Barton Pai A, Pai MP, Depczynski J, et al. Non-transferrin-bound iron is associated with enhanced Staphylococcus aureus growth in hemodialysis patients receiving intravenous iron sucrose. Am J Nephrol 2006; 26: 304-309.
20. Minneci PC, Deans KJ, Hansen B, et al. A canine model of septic shock: balancing animal welfare and scientific relevance. Am J Physiol Heart Circ Physiol 2007; 293 (4): H2487-2500.
21. Hicks CW, Sweeney DA, Danner RL, et al. Efficacy of selective mineralocorticoid and glucocorticoid agonists in canine septic shock. Crit Care Med 2012; 40: 199-207.
22. Hicks CW, Sweeney DA, Danner RL, et al. Beneficial effects of stress-dose corticosteroid therapy in canines depend on the severity of staphylococcal pneumonia. Intensive Care Med 2012; 38: 2063-2071.
23. Wang X, Tanus-Santos JE, Reiter CD, et al. Biological activity of nitric oxide in the plasmatic compartment. Proc Natl Acad Sci U S A 2004; 101: 11477-11482.
24. MacArthur PH, Shiva S, Gladwin MT,. Measurement of circulating nitrite and S-nitrosothiols by reductive chemiluminescence. J Chromatogr B Analyt Technol Biomed Life Sci 2007; 851 (1-2): 93-105.
25. Minneci PC, Deans KJ, Zhi H, et al. Hemolysis-associated endothelial dysfunction mediated by accelerated NO inactivation by decompartmentalized oxyhemoglobin. J Clin Invest 2005; 115: 3409-3417.
26. Rother RP, Bell L, Hillmen P, et al. The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA 2005; 293: 1653-1662.
27. Jeffers A, Gladwin MT, Kim-Shapiro DB,. Computation of plasma hemoglobin nitric oxide scavenging in hemolytic anemias. Free Radic Biol Med 2006; 41: 1557-1565.
28. Hu W, Jin R, Zhang J, et al. The critical roles of platelet activation and reduced NO bioavailability in fatal pulmonary arterial hypertension in a murine hemolysis model. Blood 2010; 116: 1613-1622.
29. Yu B, Raher MJ, Volpato GP, et al. Inhaled nitric oxide enables artificial blood transfusion without hypertension. Circulation 2008; 117: 1982-1990.
30. Reiter CD, Wang X, Tanus-Santos JE, et al. Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat Med 2002; 8: 1383-1389.
31. von Bonsdorff L, Sahlstedt L, Ebeling F, et al. Apotransferrin administration prevents growth of Staphylococcus epidermidis in serum of stem cell transplant patients by binding of free iron. FEMS Immunol Med Microbiol 2003; 37: 45-51.
32. Mazmanian SK, Skaar EP, Gaspar AH, et al. Passage of heme-iron across the envelope of Staphylococcus aureus. Science 2003; 299 (5608): 906-909.
33. Modun BJ, Cockayne A, Finch R, et al. The Staphylococcus aureus and Staphylococcus epidermidis transferrin-binding proteins are expressed in vivo during infection. Microbiology 1998; 144 (Pt 4): 1005-1012.
34. Bernheimer AW, Grushoff P, Avigad LS,. Isoelectric analysis of cytolytic bacterial proteins. J Bacteriol 1968; 95: 2439-2441.
35. Microbiology RT,. Pathogenic bacteria prefer heme. Science 2004; 305 (5690): 1577-1578.
36. Weinberg ED,. Iron availability and infection. Biochim Biophys Acta 2009; 1790: 600-605.
37. Cassat JE, Skaar EP,. Metal ion acquisition in Staphylococcus aureus: overcoming nutritional immunity. Semin Immunopathol 2012; 34: 215-235.
38. Jurado RL,. Iron, infections, and anemia of inflammation. Clin Infect Dis 1997; 25: 888-895.
39. Dinges MM, Orwin PM, Schlievert PM,. Exotoxins of Staphylococcus aureus. Clin Microbiol Rev 2000; 13: 16-34, table of contents.
40. Krishna Kumar K, Jacques DA, Pishchany G, et al. Structural basis for hemoglobin capture by Staphylococcus aureus cell-surface protein, IsdH. J Biol Chem 2011; 286 (44): 38439-38447.
41. Courcol RJ, Trivier D, Bissinger MC, et al. Siderophore production by Staphylococcus aureus and identification of iron-regulated proteins. Infect Immun 1997; 65: 1944-1948.
42. Dale SE, Doherty-Kirby A, Lajoie G, et al. Role of siderophore biosynthesis in virulence of Staphylococcus aureus: identification and characterization of genes involved in production of a siderophore. Infect Immun 2004; 72: 29-37.
43. Lee BC,. Quelling the red menace: haem capture by bacteria. Mol Microbiol 1995; 18: 383-390.
44. Tiedemann MT, Muryoi N, Heinrichs DE, et al. Iron acquisition by the haem-binding Isd proteins in Staphylococcus aureus: studies of the mechanism using magnetic circular dichroism. Biochem Soc Trans 2008; 36 (Pt 6): 1138-1143.
45. Esposito BP, Breuer W, Slotki I, et al. Labile iron in parenteral iron formulations and its potential for generating plasma nontransferrin-bound iron in dialysis patients. Eur J Clin Invest 2002; 32 (Suppl 1): 42-49.
46. Parkkinen J, von Bonsdorff L, Peltonen S, et al. Catalytically active iron and bacterial growth in serum of haemodialysis patients after i.v. iron-saccharate administration. Nephrol Dial Transplant 2000; 15: 1827-1834.
47. Janz DR, Bastarache JA, Peterson JF, et al. Association between cell-free hemoglobin, acetaminophen, and mortality in patients with sepsis: an observational study. Crit Care Med 2013; 41: 784-790.
48. Vermeulen Windsant IC, de Wit NC, Sertorio JT, et al. Blood transfusions increase circulating plasma free hemoglobin levels and plasma nitric oxide consumption: a prospective observational pilot study. Crit Care 2012; 16 (3): R95.
49. Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345: 1368-1377.
50. Kor DJ, Van Buskirk CM, Gajic O,. Red blood cell storage lesion. Bosn J Basic Med Sci 2009; 9 (Suppl 1): 21-27.
51. Ganz T,. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood 2003; 102: 783-788.
52. Hod EA, Spitalnik SL,. Harmful effects of transfusion of older stored red blood cells: iron and inflammation. Transfusion 2011; 51: 881-885.